+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Lupus Nephritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767680
  • Report
  • April 2019
  • Region: Global
  • 116 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Astellas Pharma Inc
  • Biogen Inc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • Immune Tolerance Network
  • Johnson & Johnson
  • MORE
The global clinical trial report- “2019 Lupus Nephritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Lupus Nephritis. It presents in-depth analysis of Lupus Nephritis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Lupus Nephritis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Lupus Nephritis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Lupus Nephritis

The research work is prepared through extensive and continuous research on Lupus Nephritis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Lupus Nephritis patients are identified
  • The report includes panorama of Lupus Nephritis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Lupus Nephritis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astellas Pharma Inc
  • Biogen Inc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • Immune Tolerance Network
  • Johnson & Johnson
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Lupus Nephritis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Lupus Nephritis Clinical Trials by Region
2.2.2 Average Enrollment of Lupus Nephritis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Lupus Nephritis Treatment, 2019

3. Region wise Lupus Nephritis Clinical Trials
3.1 Asia Pacific Lupus Nephritis Clinical Trials by Country
3.2 Europe Lupus Nephritis Clinical Trials by Country
3.3 North America Lupus Nephritis Clinical Trials by Country
3.4 Middle East and Africa Lupus Nephritis Clinical Trials by Country
3.5 South and Central America Lupus Nephritis Clinical Trials by Country

4. Lupus Nephritis Clinical Trial Trends
4.1 Start Year wise Lupus Nephritis Clinical Trials
4.2 Phase wise Lupus Nephritis Clinical Trials
4.3 Trial Status wise Lupus Nephritis Clinical Trials
4.4 Trial Type wise Lupus Nephritis Clinical Trials

5. Lupus Nephritis Average Enrollment Trends
5.1 Average Enrollment in Lupus Nephritis Trials by Year
5.2 Average Enrollment in Lupus Nephritis Trials by Phase
5.3 Average Enrollment in Lupus Nephritis Trials by Status
5.4 Average Enrollment in Lupus Nephritis Trials by Type of Trial

6. Companies Participating in Lupus Nephritis Clinical Trials
6.1 Lupus Nephritis Trials by Sponsor Type
6.2 Lupus Nephritis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Lupus Nephritis Trials- Phase 1
7.2 Lupus Nephritis Trials- Phase 2
7.3 Lupus Nephritis Trials- Phase 3
7.4 Lupus Nephritis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Lupus Nephritis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 7: North America - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Lupus Nephritis Clinical Trials and Enrolment
Figure 9: Lupus Nephritis Clinical Trials by Phase
Figure 10: Lupus Nephritis Clinical Trials by Trial Status
Figure 11: Lupus Nephritis Clinical Trials by Type
Figure 12: Lupus Nephritis Clinical Trials by Sponsor Type
Figure 13: Lupus Nephritis Clinical Trials by Leading Sponsors
Figure 14: Lupus Nephritis Average Enrollment by Phase
Figure 15: Lupus Nephritis Average Enrollment by Trial Status
Figure 16: Lupus Nephritis Average Enrollment by Type
Figure 17: Lupus Nephritis- Average Enrolment by Type of Sponsors
Figure 18: Lupus Nephritis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Lupus Nephritis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 5: Europe - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 7: North America - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Lupus Nephritis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Lupus Nephritis Average Enrollment by Phase
Table 15: Lupus Nephritis Average Enrollment by Trial Status
Table 16: Lupus Nephritis Average Enrollment by Type
Table 17: Lupus Nephritis- Average Enrolment by Type of Sponsors
Table 18: Lupus Nephritis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astellas Pharma Inc
  • Aurinia Pharmaceuticals Inc
  • Biogen Inc
  • Bristol-Myers Squibb Co
  • C. H. Boehringer Sohn AG & Co KG
  • F. Hoffmann-La Roche Ltd
  • Immune Tolerance Network
  • Johnson & Johnson
  • Novartis AG
  • Parexel International Corp
Note: Product cover images may vary from those shown
Adroll
adroll